Infraredx receives Japanese regulatory approval for multimodal intravascular imaging system

Oct. 1, 2014
Coronary artery disease medical device maker Infraredx has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the company's TVC Imaging System and TVC Insight Catheter, a multimodal technology for intravascular imaging.

Coronary artery disease medical device maker Infraredx (Burlington, MA) has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW; Tokyo, Japan) for the company's TVC Imaging System and TVC Insight Catheter, a multimodal technology for intravascular imaging. The system makes it possible to determine the structure and chemical composition of coronary plaques that complicate stenting and are associated with heart attacks. The system console and catheter will be exclusively distributed by Goodman, a subsidiary of Nipro Corporation (Osaka, Japan), which has experience commercializing intravascular ultrasound (IVUS) and other imaging technologies in Japan.

The system integrates near-infrared spectroscopy (NIRS) to detect lipid-core plaques and enhanced IVUS to visualize vessel structure, including the presence of plaques and the degree of stenosis (narrowing) due to plaque build-up. Lipid core plaque is a fatty coronary artery plaque associated with most heart attacks. The system can identify plaques suspected to be vulnerable to rupture, which can cause a heart attack.


Infraredx entered a partnership with Nipro in August 2013, when it received an initial $25 million equity investment. Goodman, now a partially owned subsidiary of Nipro, has a history in the cardiovascular market as a distributor, establishing IVUS system market leadership for Boston Scientific and later for Volcano Corporation in Japan.

-----

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Flexible, Thixotropic, One Component Dual Cure Epoxy

Dec. 1, 2023
Master Bond UV23FLDC-80TK is a moderate viscosity, cationic type system that offers both UV light and heat curing mechanisms. It cures readily within 20-30 seconds when exposed...

MRF Polishing

Dec. 1, 2023
Welcome to Avantier, your esteemed partner in optical solutions for over five decades. With a legacy of expert knowledge, we invite you to delve into the realm of precision optics...

Fluorescence Microscopy Part 1: Illuminating Samples for High-Resolution Imaging

Dec. 1, 2023
Illuminating Samples Fluorescence microscopy is a powerful imaging technique widely used in various fields, especially in biomedical research, to visualize and study fluorescently...

Photonics Business Moves: December 1, 2023

Dec. 1, 2023
Here are the top four photonics business moves that made headlines during the week ending December 1, 2023.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!